Germ cell tumors have been treated with cisplatin-based chemotherapy since the 1970s. While approximately 80% of patients respond well to cisplatin, the remaining 20% do not.For those patients, treatment options are limited, and when the cancer returns after second- and third-line treatments, cancer-related mortality is over 90%.
Your privacy is our priority
- Hosted on Secure cloud-based hosting
- SOC II Type 1
- HIPAA compliant
- 2FA authentication
- End-to-end data encryption
- Your health data will not be sold or used without your consent. Ever.
